Torrent Pharma gets clean FDA chit, boosts JB Chemicals stake to 48.75%

• Torrent Pharmaceuticals' Dahej facility received a clean chit from the US FDA after a January 19-23, 2026 inspection with zero observations.
• The company increased its stake in JB Chemicals & Pharmaceuticals to 48.75% by acquiring an additional 2.36% equity.
• This acquisition is part of Torrent Pharma's strategy to consolidate its holding in JB Chemicals, following previous stake increases.
• Torrent Pharma reported a 30.4% YoY rise in Q2FY26 net profit to ₹591 crore and a 14.3% revenue increase to ₹3,302 crore.
• The India business, the largest contributor, grew 12% to ₹1,820 crore, driven by strong performance in focus therapies and chronic portfolio.

Why It Matters: Torrent Pharma secured a clean FDA inspection report and strategically increased its stake in JB Chemicals.